
    
      The study duration per subject will be 36-99 days and will consist of a screening period of 2
      to 21 days, a study period of 7 days for each of four periods, and a washout of 8-21 days
      between each dose administration, and a final follow up visit 10-15 days after final dose
      administration.
    
  